🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized multicentre phase II trial with a large translational ...
Status
Completed
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2020-10-14
Trial ID
NCT04469556
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, dosimetr...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2024-09-08
Trial ID
NCT06376253
Treatments Being Tested
This study is a Phase I/II trial of Tivantinib plus FOLFOX for the treatmen...
Status
Completed
Location
Yale University School of Medicine
Start Date
2012-07
Trial ID
NCT01611857
Treatments Being Tested
The FACT Biomarker Subgroup Analysis is a pilot study of mothers who partic...
Status
Completed
Location
The Moncton Hospital
Start Date
2011-12-19
Trial ID
NCT03981029
HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which spec...
Status
Recruiting
Location
The Second Affiliated Hospital Zhejiang University
Start Date
2024-10-03
Trial ID
NCT06825624
Treatments Being Tested
Globally, 250 million children do not reach their developmental potential a...
Status
Active Not Recruiting
Location
Universidad San Francisco de Quito
Start Date
2022-01-05
Trial ID
NCT05242224
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of lisocab...
Status
Recruiting
Location
University Of Colorado
Start Date
2025-11-06
Trial ID
NCT07015242
This Phase III, multicenter, randomized, open-label, controlled study is de...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2026-07
Trial ID
NCT07595913
Treatments Being Tested
Objective The main objective is to evaluate the haematological toxicity in ...
Status
Unknown
Location
Amphia Hospital
Start Date
2023-02-06
Trial ID
NCT06010277
Treatments Being Tested
Treatment with FOLFOXIRI (5-fluorouracil, oxaliplatin, irinotecan) can be e...
Status
Completed
Location
Department of Oncology, Vejle Hospital
Start Date
2016-05-06
Trial ID
NCT02705300